Spago Nanomedical Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Fredrik Laurell, was filed 29 Jul 2026.
Spago Nanomedical: what insiders have been doing
This page follows insider dealings at Spago Nanomedical as filed with Finansinspektionen, a company from the Health Care sector. Over the twelve months to 22 October 2026, 7 filings were filed, from 5 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €13k, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €8,996 from Hakasan AB Hakasan AB, disclosed on 29 July 2026, or 0.13% of market capitalisation. On the buying side, the filings list 2 chief executives among the declarants.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 29 July 2026, 102 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
With 7 filings in twelve months, the company is quieter than the median of 8 filings across the 882 companies we follow on the same exchange. Since 2016, the database holds 9 purchases and 4 sales by insiders of the company.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 45,454 shares@ SEK 1.100.067% mcap100.0% of flowAktieISIN SE0005506185FI:csv-a224524b798a81ced059Canonical exit: 27 Oct 2026 (T+90)
- 90,909 shares@ SEK 1.100.13% mcap100.0% of flowAktieISIN SE0010766105FI:csv-2764dfad35eeb1863c99Canonical exit: 27 Oct 2026 (T+90)
- 59,846,450 shares0AktieISIN SE0010766105FI:csv-770b9f3dabe8a167a46b
- 3,927,154 shares0AktieFI:csv-519659ba803656a1cc60
- 96,076 shares0AktieFI:csv-840e03c8e40bdfe5ee07
- 1,867,578 shares0AktieFI:csv-8397b76ae78ee6074ba3
- 20,000 shares@ SEK 47.61100.0% of flowAktieISIN SE0010766105FI:csv-bcd28bfbf786f4536b4d
- 2,775,002 shares@ SEK 0.194100.0% of flowAktieISIN SE0010766105FI:A003R288-1
- 50,000 shares@ SEK 0.7814.9% of flowAktieISIN SE0004899474FI:csv-02badc5fa0f5626a284fCanonical exit: 4 May 2023 (T+90)
- 3,477,319 shares@ €0.3867100.0% of flowAktieISIN SE0015837752FI:A001S144-1
- 800,000 shares0TeckningsoptionISIN SE0010440842FI:csv-8bd1a79411066c39775b
- 160,000 shares@ SEK 8.50AktieISIN SE0004899474FI:csv-93d64b770a26cae97bbc
- 1,275,552 shares@ SEK 0.21100.0% of flowTeckningsoptionISIN SE0010440842FI:csv-a5e51f2791676e35b8b3
- 2,000 shares@ SEK 11.90AktieISIN SE0004899474FI:csv-f9860368b08770df71bcCanonical exit: 1 Jan 2019 (T+90)
- 129,031 shares@ SEK 0.7748.3% of flowISIN SE0010133538FI:csv-53f9357bde3c53e0d221
- 780,000 shares0ISIN SE0004899474FI:csv-52a9e5cf1f2ce3e4e0c7
- 4,886 shares@ SEK 8.50ISIN SE0010440834FI:csv-42653b5749a9624ee10b
- 7,333 shares@ SEK 8.50ISIN SE0004899474FI:csv-53ada97368e8f6de32d8
- 129,031 shares@ SEK 0.77100.0% of flowFI:csv-8f5aaf9c254f092d0e3dCanonical exit: 10 Sept 2017 (T+90)
- 344,083 shares@ SEK 0.77100.0% of flowFI:csv-094d2190a4ba1891d185Canonical exit: 10 Sept 2017 (T+90)
- 129,031 shares@ SEK 0.7751.7% of flowFI:csv-fc3a59c14c5b5099a84aCanonical exit: 10 Sept 2017 (T+90)
- 42,000 shares@ SEK 12.00ISIN SE0004899474FI:csv-7ce55497825971dca561Canonical exit: 14 Mar 2017 (T+90)
- 391,406 shares@ SEK 12.85ISIN SE0004899474FI:csv-c79932c7f833f0d6ffa3
- 20,045 shares@ SEK 14.10ISIN SE0004899474FI:csv-a17ea1e1d6f91a306d8eCanonical exit: 7 Mar 2017 (T+90)
24 of 24 declarations
About Spago Nanomedical
Spago Nanomedical is a company focused on developing targeted cancer treatments using nanomedicine technologies. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
